HOMA-IR
HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) estimates fasting insulin sensitivity from two numbers you can pull from any standard lab: fasting glucose and fasting insulin. The formula, glucose in mg/dL multiplied by insulin in µIU/mL, divided by 405, gives a single ratio that catches insulin resistance years before fasting glucose or hemoglobin A1c drift above the diabetic threshold.
Why this biomarker matters
Insulin resistance is the earliest detectable rung on the ladder that ends in type 2 diabetes, fatty liver disease, and accelerated cardiovascular disease. By the time hemoglobin A1c crosses into pre-diabetic territory (5.7 percent), insulin output has often been compensating for a decade or more. HOMA-IR catches that compensation: a fasting insulin of 12 µIU/mL with a glucose of 95 looks reassuring on either marker alone but yields a HOMA-IR of 2.8, clearly above the insulin-resistant threshold. Reference values are well established. HOMA-IR under 1.0 indicates excellent insulin sensitivity, typical of trained, lean, healthy young adults. Values between 1.0 and 1.9 are unremarkable. From 2.0 to 2.5 suggests early insulin resistance; above 2.5 is consistent with metabolic syndrome; above 4.0 typically accompanies overt type 2 diabetes. The marker responds quickly to weight loss, structured exercise (especially zone-2 and resistance training), and time-restricted eating, meaningful HOMA-IR drops are routinely seen within eight to twelve weeks.
Weekly performance intelligence.
New studies, protocols, and optimization frameworks delivered every Monday. No fluff, no motivation quotes — only what moves the needle.